Skip to main content
Benjamin Gaston, MD, Pediatric Pulmonology, Indianapolis, IN, Riley Hospital for Children at IU Health

BenjaminM.GastonMD

Pediatric Pulmonology Indianapolis, IN

Professor, Pediatrics, Indiana University

Dr. Gaston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gaston's full profile

Already have an account?

  • Office

    Wells Center for Pediatric Research, Riley Hospital
    1044 W. Walnut St., R4-476
    Indianapolis, IN 46202
    Phone+1 317-278-2705
    Fax+1 434-982-3816
  • Is this information wrong?

Summary

  • I am a board certified Pulmonologist. I manage severe asthma, Primary Ciliary Dyskinesia and Aerodigestive Disorders

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterFellowship, Pediatric Pulmonology, 1990 - 1993
  • National Capital Consortium
    National Capital ConsortiumInternship, Transitional Year, 1983 - 1984
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - Present
  • IN State Medical License
    IN State Medical License 2019 - 2025
  • OH State Medical License
    OH State Medical License 2012 - 2021
  • WV State Medical License
    WV State Medical License 1999 - 2014
  • VA State Medical License
    VA State Medical License 1985 - 2014
  • American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

  • Physician-Scientist of the Year, 2017 University Hospitals, Cleveland
  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Analysis Reveals Rare Disease Is More Common Than Previously Thought
    Analysis Reveals Rare Disease Is More Common Than Previously ThoughtJanuary 24th, 2022
  • Atelerix Life Sciences Appoints James Bates, MD, as Chief Medical Officer
    Atelerix Life Sciences Appoints James Bates, MD, as Chief Medical OfficerSeptember 14th, 2021
  • Case Western Reserve and Atelerix Life Sciences Inc. Sign Option License to Develop New Therapeutic Approach to Opioid Crisis
    Case Western Reserve and Atelerix Life Sciences Inc. Sign Option License to Develop New Therapeutic Approach to Opioid CrisisApril 20th, 2021
  • Join now to see all

Grant Support

  • Clinical Centers for the NHLBI's Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) Network (UG1).NIH2017–2023
  • Personalized small molecule therapy for severe asthma and cystic fibrosisNIH2016–2021
  • Airway redox biochemistry as a determinant of asthma phenotypeNIH2011–2020
  • S-Nitrosothiol Localization And Signaling In Airway Epithelial CellsNational Heart, Lung, And Blood Institute2011–2012
  • Administrative CoreNational Heart, Lung, And Blood Institute2011–2012
  • "Cellular S-Nitrosothiol Signaling In Respiratory Biology"National Heart, Lung, And Blood Institute2011–2012
  • Airway Redox Biochemistry As A Deteriminant Of Asthma Phenotype During Adolescen*National Heart, Lung, And Blood Institute2011
  • S-Nitrosothiol Breakdown By Airway Epithelial CellsNational Heart, Lung, And Blood Institute1999–2011
  • Severe Asthma Research ProgramNational Center For Research Resources2008–2010
  • S-Nitrosotiol Breakdown By Airway Epithelial CellsNational Heart, Lung, And Blood Institute2007
  • Redox Determinants Of Severe Asthma.National Heart, Lung, And Blood Institute2001–2005
  • Role Of Airway Epithelial Glutaminase In AsthmaNational Institute Of Allergy And Infectious Diseases2001–2002
  • Airway Nitrogen Oxide Balance And Cystic Fibrosis: Pilot StudyNational Center For Research Resources1999–2000

Professional Memberships

Hospital Affiliations